Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

John Brottem Biography and Net Worth

General Counsel of Outset Medical

John Brottem joined Outset as General Counsel in May 2020. He brings nearly two decades of experience leading legal teams within the healthcare and technology industries. John joined the company from Omnicell where he most recently served as Vice President and Deputy General Counsel. At Omnicell John was involved in a range of activities including public company reporting, corporate governance, M&A and strategic transactions, sales and marketing support, compliance, regulatory, IP and litigation. He previously served as corporate counsel at Brocade Communications Systems and Foundry Networks, and spent six years as an associate in the business department of Cooley LLP.
John received his undergraduate degree from Occidental College and his JD from the University of California, Davis, School of Law.

What is John L. Brottem's net worth?: The estimated net worth of John L. Brottem is at least $588,110.40 as of February 15th, 2024. Mr. Brottem owns 245,046 shares of Outset Medical stock worth more than $588,110 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Brottem may own. Additionally, Mr. Brottem receives a salary of $594,150.00 as General Counsel at Outset Medical. Learn More about John L. Brottem's net worth.
How old is John L. Brottem?: Mr. Brottem is currently 49 years old. There are 5 older executives and no younger executives at Outset Medical. The oldest executive at Outset Medical is Mr. Mark Gordon M.S., Chief Regulatory & Quality Officer, who is 67 years old. Learn More on John L. Brottem's age.
What is John L. Brottem's salary?: As the General Counsel of Outset Medical, Inc., Mr. Brottem earns $594,150.00 per year. There are 2 executives that earn more than Mr. Brottem. The highest earning executive at Outset Medical is Ms. Leslie L. Trigg, President, CEO & Chairman, who commands a salary of $1,220,000.00 per year. Learn More on John L. Brottem's salary.
How do I contact John L. Brottem?: The corporate mailing address for Mr. Brottem and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on John L. Brottem's contact information.
Has John L. Brottem been buying or selling shares of Outset Medical?: John L. Brottem has not been actively trading shares of Outset Medical within the last three months. Most recently, John L. Brottem sold 3,341 shares of the business's stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $3.57, for a transaction totalling $11,927.37. Following the completion of the sale, the general counsel now directly owns 245,046 shares of the company's stock, valued at $874,814.22. Learn More on John L. Brottem's trading history.
Who are Outset Medical's active insiders?: Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.
Are insiders buying or selling shares of Outset Medical?: In the last year, insiders at the sold shares 34 times. They sold a total of 183,768 shares worth more than $2,821,339.29. The most recent insider tranaction occured on March, 15th when SVP Marc Nash sold 2,391 shares worth more than $5,092.83. Insiders at Outset Medical own 3.5% of the company. Learn More about insider trades at Outset Medical.
Information on this page was last updated on 3/15/2024.

John L. Brottem Insider Trading History at Outset Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2024	Sell	3,341	$3.57	$11,927.37	245,046
1/16/2024	Sell	1,480	$4.29	$6,349.20	248,387
1/8/2024	Sell	7,344	$5.49	$40,318.56	48,807
7/19/2023	Sell	1,415	$20.00	$28,300.00	58,945
6/20/2023	Sell	1,414	$21.97	$31,065.58	58,945
5/17/2023	Sell	2,732	$20.08	$54,858.56	58,945
5/3/2023	Sell	1,414	$20.00	$28,280.00	61,597
3/20/2023	Sell	4,130	$20.82	$85,986.60	61,597
2/16/2023	Sell	1,358	$24.36	$33,080.88	66,422
1/27/2023	Sell	4,282	$27.92	$119,553.44	67,780
11/30/2022	Sell	12,761	$20.34	$259,558.74	31,044
11/18/2022	Sell	1,918	$19.00	$36,442.00	31,044
8/16/2022	Sell	351	$21.48	$7,539.48	33,314
5/17/2022	Sell	349	$26.36	$9,199.64	33,665
4/18/2022	Sell	2,415	$43.25	$104,448.75	34,014
3/17/2022	Sell	1,400	$40.46	$56,644.00
3/15/2022	Sell	6,586	$38.59	$254,153.74
3/1/2022	Sell	1,003	$43.73	$43,861.19
2/15/2022	Sell	10,002	$35.92	$359,271.84
1/18/2022	Sell	10,002	$35.61	$356,171.22
1/3/2022	Sell	2,500	$47.05	$117,625.00
12/1/2021	Sell	3,500	$47.92	$167,720.00
11/15/2021	Sell	4,945	$51.40	$254,173.00
10/19/2021	Sell	1,445	$50.00	$72,250.00
10/15/2021	Sell	3,500	$49.02	$171,570.00
9/15/2021	Sell	4,945	$50.35	$248,980.75
9/7/2021	Sell	2,890	$50.00	$144,500.00
8/16/2021	Sell	3,500	$38.68	$135,380.00	18,172
7/15/2021	Sell	3,500	$43.83	$153,405.00	18,172
6/17/2021	Sell	1,445	$50.00	$72,250.00	16,117
6/15/2021	Sell	3,500	$47.87	$167,545.00	18,172
5/17/2021	Sell	3,500	$42.34	$148,190.00	18,172
4/15/2021	Sell	3,500	$54.17	$189,595.00	18,172
3/18/2021	Sell	3,500	$47.71	$166,985.00	18,172

John L. Brottem Buying and Selling Activity at Outset Medical

Outset Medical Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Today's Range

Now: $2.40

$2.34

$2.45

50 Day Range

MA: $2.54

$1.94

$3.79

2 Week Range

Now: $2.40

$1.92

$24.13

Volume

402,874 shs

Average Volume

1,022,301 shs

Market Capitalization

$124.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

4 simple steps to protect your privacy and money before it’s too late.

John Brottem Biography and Net Worth

What is John L. Brottem's net worth?

How old is John L. Brottem?

What is John L. Brottem's salary?

How do I contact John L. Brottem?

Has John L. Brottem been buying or selling shares of Outset Medical?

Who are Outset Medical's active insiders?

Are insiders buying or selling shares of Outset Medical?